{
  "trial_id": "NCT04315350",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "elevated IOP is asymptomatic",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "participants are more prone to infections and have fewer symptoms of infections",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "withdrawal symptoms are unlikely due to short treatment period and low dose",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "MRS is safe and not coupled with discomfort or pain",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "penetrations of skin are associated with mild discomfort and risk of hematomas",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "total blood loss is not harmful for the participant",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "participants physical and mental integrity and privacy will be protected",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "the protocol complies with the Helsinki Declaration",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "the project is not supported by any medical companies",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "participants will be asked about their wellbeing and symptoms of infection several times during the trial",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "extra restrictions and assessments are applied in case of COVID19 pandemic",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "participants will be offered a referral to the Department of Gastroenterology if they have steatosis on both MRS",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "randomisation visit will be planned within 6 weeks from the screening visit",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "participants will undergo an MRS of the liver before intervention start",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "stool samples will be collected by the participant at home",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "participants will meet in the laboratory around 8 a.m. after 10 hours of fast and refrainment from tobacco or nicotine supplements use",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "the participant will be tested for Sars-Cov2 with a swab procedure in the oropharynx, for immidiate PCR analysis if the test day is during COVID19 pandemic",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "fasting urine sample will be collected and the participant is asked to empty the urinary bladder completely",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "fasting blood samples will be collected for various biomarkers and tests",
      "label": "triggers",
      "evidence": "none"
    }
  ],
  "notes": "",
  "_meta": {
    "topic_id": "21",
    "trial_id": "NCT04315350",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}